Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion type Assertion NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_head.
- NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in GBC and will be a novel therapeutic target as an enhancer of sensitivity to 5-FU-based regimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_provenance.
- NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion evidence source_evidence_literature NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_provenance.
- NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion SIO_000772 18692501 NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_provenance.
- NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion wasDerivedFrom befree-20140225 NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_provenance.
- NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion wasGeneratedBy ECO_0000203 NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_provenance.